AccurKardia receives patent for AI-ECG cardiac amyloidosis detection

MobiHealthNews

AccurKardia granted U.S. patent for ML-based system to detect cardiac amyloidosis from standard 12-lead ECG. Patent positions company to expand investigational AI-ECG pipeline into disease often delayed in diagnosis.

MobiHealthNews·Eve Bender

7 days ago